CD47 and melanoma: In addition, the combination of a tumour-specific antibody with CD47 blockade failed to meaningfully enhance the phagocytosis of three human melanoma cell lines, although SKMEL28 cells were sensitive to phagocytosis with an opsonizing antibody.